Hoddesdon
United Kingdom
23
2016-01-28
23
2016-12-27
These are the the leading inventors for applications assigned to Merck Sharp & Dohme Lt.d.:
Merck Sharp & Dohme Lt.d. based in Hoddesdon, GB has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Process for preparing chiral dipeptidyl peptidase-IV inhibitors
#2 | 2015-04-09 β Patent 9,181,262 granted on 2015-11-10Crystalline forms of a dipeptidyl peptidase-IV inhibitors
#3 | 2014-04-17 β Patent 9,187,488 granted on 2015-11-17Process for preparing chiral dipeptidyl peptidase-IV inhibitors
#4 | 2014-03-20 β Patent 8,895,603 granted on 2014-11-25Crystalline forms of a dipeptidyl peptidase-IV inhibitor
#5 | 2010-04-22 β Patent 7,834,222 granted on 2010-11-16Process for the preparation of bicyclo[3.1.0]hexanols
#6 | 2007-06-07 β Patent 7,449,585 granted on 2008-11-11Indazol-3-ones and analogues and derivatives thereof which modulate the function of the vanilloid-1 receptor (VR1)
#7 | 2007-06-05 β Patent 7,226,922 granted on 2007-06-05Imidazo[1,2-b]pyridazine analogues as anxiolytics and cognition enhancers
#8 | 2006-12-05 β Patent 7,144,887 granted on 2006-12-05Substituted 1,2,3-triazolo[1,5-a]quinazolines for enhancing cognition
#9 | 2006-07-06 β Patent 7,288,655 granted on 2007-10-30Ξ± v integrin receptor antagonists
#10 | 2006-06-13 β Patent 7,060,710 granted on 2006-06-13Isoxazole pyrazoloindane derivatives as cognition enhancing GABAΞ±5 subtype ligands
#11 | 2006-04-18 β Patent 7,030,128 granted on 2006-04-18Imidazo-pyrimidine derivatives as ligands for GABA receptors
#12 | 2006-04-04 β Patent 7,022,724 granted on 2006-04-04Cognition enhancing derivatives of isoxazole triazoloindane GABA-A Ξ±5 receptor subunit ligands
#13 | 2006-03-09 β Patent 7,226,926 granted on 2007-06-058-fluoroimidazo 1,2-a pyridine derivatives as ligands for GABA receptors
#14 | 2006-02-23 β Patent 7,442,701 granted on 2008-10-28Amino-heterocycles as VR-1 antagonists for treating pain
#15 | 2006-01-10 β Patent 6,984,626 granted on 2006-01-10Gamma-secretase inhibitors
#16 | 2005-11-15 β Patent 6,964,981 granted on 2005-11-15Tetrahydrofuran derivatives and their use as NK-1 antagonists
#17 | 2005-09-29 β Patent 7,041,688 granted on 2006-05-09Alkynly-substituted spirocyclic sulfamides for the treatment of alzheimer's disease
#18 | 2005-09-27 β Patent 6,949,549 granted on 2005-09-27Imidazolophthalazine derivatives as ligands for GABAA receptors
#19 | 2005-09-20 β Patent 6,946,461 granted on 2005-09-20Imidazolophthalazine derivatives as ligands for GABAA receptors
#20 | 2005-08-18 β Patent 7,041,689 granted on 2006-05-09Heteroaryl substituted spriocyclic sulfamides for inhibition of gamma secretase
#21 | 2005-06-02 β Patent 7,157,478 granted on 2007-01-02Oxadiazole derivatives for inhibition of gamma secretase
#22 | 2005-05-31 β Patent 6,900,215 granted on 2005-05-31Imidazo-pyrimidine derivatives as ligands for gaba receptors
#23 | 2005-03-29 β Patent 6,872,731 granted on 2005-03-29Imidazo-pyridine derivatives as ligands for GABA receptors
Also check out Merck Sharp & Dohme Ltd.'s (Hoddesdon, United Kingdom) applicant profile with 2 patent applications submitted.
364101 β